Artal Group S.A. Forma Therapeutics Holdings, Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$5.1 - $10.0 $5.1 Million - $10 Million	-1,000,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.58 - $42.82 $12.3 Million - $21.4 Million	500,000 Added 100.0%	1,000,000 $28 Million
Q4 2020 Feb 11, 2021	BUY	$34.9 - $51.08 $17.5 Million - $25.5 Million	500,000 New	500,000 $17.5 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.